Halifax, Nova Scotia-based ABK Biomedical Inc., which focuses on biomaterials invented by Bob Abraham, Daniel Boyd and Sharon Kehoe, appointed Michael Mangano as president and CEO. Mangano will be responsible for leading global business activities, including the development, regulatory approval and commercialization of ABK's technologies. Mangano most recently served as president and CEO of Reshape Medical.
Bluewind Medical, of Herzliya, Israel, appointed Roger Dmochowski of Vanderbilt University as the company's CMO. Dmochowski will lead clinical efforts, including the upcoming OASIS (OverActive bladder StImulation System) pivotal trial of Renova Istim for the management of overactive bladder.
Oncosec Medical Inc., of Pennington, N.J., and San Diego, named Robert Ashworth as vice president, regulatory.
Portola Valley, Calif.-based Transmed7 LLC reported the appointment of John Simpson as strategic advisor to the company's board of directors.